Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies, Sardi et. al.
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease, Neumann et. al.